The global single-use ophthalmic surgical devices market size was valued at USD 5.2 billion in 2018 and is projected to expand at a CAGR of 6.5% by 2026. Increasing in several ophthalmic complications such as myopia, cataract, diabetic retinopathy, and others are expected to drive the market. Preference of single-use instruments over reusable devices for eye surgery is growing at a significant pace. Single-use ophthalmic surgical instruments provide safety and are available in a wide range of shapes and sizes, which helps in optimizing accuracy in surgical procedures. Besides, single-use devices aid in minimizing maintenance costs resulting from cleaning and sterilization.
Single-use devices for eye surgeries reduce the chances of post-operative complications. This is because these devices are not repeatedly used after sterilization, which in many situations, could lead to cross-contamination and other hospital-acquired infections. Moreover, ophthalmic surgeries are premium priced surgical procedures that require safer and sharp surgical devices. An increasing number of surgeries, and efforts to reduce overall operation costs, are some of the factors expected to drive the market.
Favorable reimbursement policies for surgical treatment of ophthalmic disorders such as cataract, diabetic retinopathy, and myopia is expected to contribute toward market growth in developed countries. Strict regulations for post-use processing of single-use devices and effective guidelines by Joint Commission International (JCI) are expected to lower a negative impact on the environment, thus promoting the use of single-use devices.
However, factors such as high price, low adoption rate, and limited product reach are expected to impede the market in low-GDP countries. Nevertheless, a rapidly growing number of local manufacturers that offer products at competitive prices is expected to increase the adoption of single-use surgical devices in regions with price-sensitive customers.
Based on product, single-use ophthalmic surgical devices include forceps, speculums, nuclear rotators and choppers, curettes, cannulas, knives, OVD, and others. Forceps held the largest market share in 2018. Easy accessibility and affordability of forceps are some of the major factors contributing to its growth. Moreover, major players in the market are developing single-use ophthalmic surgical forceps.
The nucleus rotators and choppers segment also held a significant share in 2018 and will register a CAGR of 6.9% during the forecast period. The major factor driving the segment is its growing adoption during cataract surgery. The tip of these choppers is designed in such a way that they provide complete control to surgeons while performing the surgery. Moreover, this device helps in efficiently disassembling the cataract nucleus without causing any harm to the delicate endothelial cells. Therefore, growing efficiency in performing cataract surgery and an increasing number of cataract cases are expected to contribute to the growth of this segment.
The ophthalmic viscosurgical devices (OVDs) segment is expected to grow at the fastest pace during the forecast period. Availability of OVDs in prefilled syringes and a growing number of cataract surgeries are driving the market for OVDs. Increasing the application of OVDs in other ophthalmic surgeries and increasing the reach of global players will also fuel segment growth.
Based on application, the single-use ophthalmic surgical devices market is segmented into diabetic retinopathy, cataract surgery, glaucoma surgery, refractive surgery, corneal surgery, vitreoretinal surgery, and others. Cataract surgery held the largest market share in 2018 and is expected to grow at a moderate rate during the forecast period. Increasing geriatric population and rising number of cataract surgeries being performed are factors aiding in the segment’s growth.
The refractive surgery segment is expected to grow at the fastest rate during the forecast period. The growth of the segment is mainly because of the myopia epidemic. The introduction of advanced IOLs and implanted contact lenses is expected to boost market growth. Therefore, the growing prevalence of these disorders and increasing demand for lenses to correct them is expected to contribute toward the growth of this segment. The diabetic retinopathy segment is expected to exhibit significant growth during the forecast period. The segment is driven by the increasing prevalence of diabetes-related ophthalmic diseases. For instance, the number of people suffering from diabetes mellitus is expected to reach 79.4 million by 2030.
Based on end-use, the market is segmented into hospitals, ophthalmic clinics, ambulatory surgery centers (ASCs), and others. Hospitals held the largest market share in 2018. The increasing procedural volume of ophthalmic surgical procedures, favorable reimbursement policies in developed countries, and improving healthcare facilities are factors contributing toward the segment growth. Besides, hospitals largely prefer single-use ophthalmic devices over reusable ones to avoid the cost burden involved with the maintenance of the latter.
Ophthalmic clinics are expected to witness significant growth during the forecast period. This growth is due to an increasing number of ophthalmologists and optometrists offering individual services. Moreover, growing awareness regarding eye-related disorders and the contribution of non-profit organizations toward the development of ophthalmic care is expected to drive the segment.
Ambulatory surgery centers are expected to experience the fastest growth during the forecast period. This growth is contributed by favorable reimbursement options for ophthalmic surgical procedures in ASCs. Moreover, an increasing number of ASCs in different regions is expected to play a pivotal role in the segment’s growth.
North America held around 34.5% of the market in 2018. The presence of a large patient pool and strong market players in this region is expected to drive regional growth. For instance, currently, in the U.S. there are around 24 million cataract patients and around 7 million have been diagnosed with diabetic retinopathy. Favorable reimbursement policies in the region for various surgical procedures are also expected to contribute toward segment growth.
Europe accounted for the second-largest share in the market in 2018. This is due to a gradual increase in the number of patients with diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma. According to a EUREYE study, currently, more than 3.3% of the European geriatric population is suffering from AMD. Moreover, the region is experiencing a rise in diabetic retinopathy cases due to the increasing prevalence of diabetes. Growing awareness regarding ophthalmology care is also driving the regional market.
Asia Pacific is anticipated to register the fastest CAGR over the forecast period due to the rising adoption of advanced technologies and an increase in favorable reimbursement policies. Moreover, countries such as China and India provide financial support to healthcare institutions for improving healthcare facilities and research institutions. This aids in researching the development and launch of advanced solutions in the field of ophthalmology. Increasing government, as well as non-government initiatives for the development of ophthalmic care in the region, will drive segment growth.
Leading players in the market include BVI; BLINK MEDICAL; Stephen Instruments; Surgitrac Instruments UK Limited; Sterimedix Ltd; Accutome Inc.; Alcon Vision LLC; Rumex International Co.; BAUSCH & LOMB INCORPORATED; APPASAMY ASSOCIATES; MANI, INC.; and Carl Zeiss Meditec AG. The market is highly fragmented with the presence of a large number of global as well as local players.
The market is expected to witness a significant number of strategic initiatives like mergers and acquisitions over the coming years. In April 2017, BVI acquired Malosa Medical, a manufacturer and supplier of single-use surgical instruments, to widen its single-use devices product portfolio in the field of ophthalmology.
Report Attribute |
Details |
The market size value in 2020 |
USD 5.8 billion |
The revenue forecast in 2026 |
USD 8.5 billion |
Growth Rate |
CAGR of 6.5% from 2019 to 2026 |
The base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, Italy, Spain, China, India, Japan, Thailand, South Korea Mexico, Brazil, Colombia, Argentina, South Africa, Saudi Arabia, UAE |
Key companies profiled |
BVI; BLINK MEDICAL; Stephen Instruments; Surgitrac Instruments UK Limited; Sterimedix Ltd; Accutome Inc.; Alcon Vision LLC; Rumex International Co.; BAUSCH & LOMB INCORPORATED; APPASAMY ASSOCIATES; MANI, INC; Carl Zeiss Meditec AG |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global single-use ophthalmic surgical devices market report based on product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Forceps
Speculum
Nucleus Rotators & Choppers
Curettes
Cannulas
Knives
OVD
Others
Application Outlook (Revenue, USD Million, 2015 - 2026)
Diabetic Retinopathy
Cataract Surgery
Glaucoma Surgery
Refractive Surgery
Corneal Surgery
Vitreo-Retinal Surgery
Others
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Hospitals
Ophthalmic clinic
ASCs
Others
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.